glp 1 receptor antagonist drugs Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Agonists: A Scoping Review Exploring the Side Effects of
Description
doi: 10.1186/s13048-021-00867-0 20 DengHChenYXingJZhangNXuL
Common side effects include nausea, vomiting, diarrhoea, abdominal pain, and reduced appetite, especially when starting or increasing the dose
M., Herrmann, K
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, chronic weight management
Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, and Schmiegel WH
